Phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A); killer cell lectin-like receptor subfamily K member 1 (KLRK1; CD314; NKG2D) BriefCommunication Pages: 392 - 392
Notch homolog 1 translocation-associated (Drosophila) (NOTCH1); mammalian target of rapamycin (mTOR; FRAP; RAFT1); γ-secretase BriefCommunication Pages: 393 - 393
Vascular endothelial growth factor receptor (VEGFR); platelet-derived growth factor receptor (PDGFR) BriefCommunication Pages: 398 - 398
Insulin-like growth factor 1 (IGF1); IGF1 receptor (IGF1R); IL-6; IL-6 receptor (IL-6R) BriefCommunication Pages: 399 - 399
Speckle-type POZ protein (SPOP); c-jun N-terminal kinase (MAPK8; JNK) BriefCommunication Pages: 400 - 400
Protein tyrosine phosphatase, receptor type, J (PTPRTJ; CD148); glycoprotein VI (platelet) (GP6; GPVI) BriefCommunication Pages: 402 - 402
Cystathionine β-synthase (CBS); cystathionase (cystathionine γ-lyase) (CTH) BriefCommunication Pages: 405 - 405
Tumor necrosis factor (TNF) and nitric oxide synthase 2 (inducible) (NOS2; iNOS)-producing dendritic cells (tipDCs) BriefCommunication Pages: 408 - 408
Thyrotropin-releasing hormone receptor (TRHR); SNP rs16892496; SNP rs7832552 BriefCommunication Pages: 413 - 413
Fusion (involved in t(12;16) in malignant liposarcoma) (FUS; TLS) BriefCommunication Pages: 416 - 416
Fusion (involved in t(12;16) in malignant liposarcoma) (FUS; TLS) BriefCommunication Pages: 417 - 417
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor (GRIA; AMPAR); brain-derived neurotrophic factor (BDNF) BriefCommunication Pages: 419 - 419
Conditional transposon-based genetic screening system for identification of cancer-associated genes (Sleeping Beauty Transposon system) BriefCommunication Pages: 421 - 421
piggyBac transposon-mediated reprogramming of somatic cells into induced pluripotent stem (iPS) cells BriefCommunication Pages: 422 - 422
Biosynthetic pathway for the production of thiopeptide antibiotics BriefCommunication Pages: 423 - 423